AtriCure Inc
NASDAQ:ATRC
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
19.86
42.53
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
AtriCure Inc
AtriCure Inc
Accounts Payable
AtriCure Inc
Accounts Payable Peer Comparison
BDX
BSX
SYK
ABT
ISRG
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AtriCure Inc
NASDAQ:ATRC
|
Accounts Payable
$103.5m
|
CAGR 3-Years
81%
|
CAGR 5-Years
49%
|
CAGR 10-Years
29%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accounts Payable
$5.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Payable
$907m
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
|
Stryker Corp
NYSE:SYK
|
Accounts Payable
$1.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
15%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Payable
$4.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Payable
$218.7m
|
CAGR 3-Years
22%
|
CAGR 5-Years
11%
|
CAGR 10-Years
15%
|
See Also
What is AtriCure Inc's Accounts Payable?
Accounts Payable
103.5m
USD
Based on the financial report for Sep 30, 2024, AtriCure Inc's Accounts Payable amounts to 103.5m USD.
What is AtriCure Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
29%
Over the last year, the Accounts Payable growth was 322%. The average annual Accounts Payable growth rates for AtriCure Inc have been 81% over the past three years , 49% over the past five years , and 29% over the past ten years .
You don't have any saved screeners yet
